Other Subjects

The Discovery of SB-435495: A Potent, Orally Active Inhibitor of Lipoprotein-Associated Phospholipase A₂ for Evaluation in Man.

Stephen A. Smith

GlaxoSmithKline Med. Res. Cent., Stevenage, Hertfordshire SG1 2NY, UK

et al. et al.

GlaxoSmithKline Med. Res. Cent., Stevenage, Hertfordshire SG1 2NY, UK

Stephen A. Smith

GlaxoSmithKline Med. Res. Cent., Stevenage, Hertfordshire SG1 2NY, UK

et al. et al.

GlaxoSmithKline Med. Res. Cent., Stevenage, Hertfordshire SG1 2NY, UK

First published: 05 March 2003

Share a link

For Abstract see ChemInform Abstract in Full Text.

References

February 11, 2003